Multiple Sclerosis Clinical Trial

The MS-LINK™ Outcomes Study

Summary

The Multiple Sclerosis (MS) Leadership and Innovation Network (MS-LINKâ„¢) is comprised of networks working cooperatively to advance Multiple Sclerosis (MS) science and improve MS participant outcomes. In this study participants will be followed from the time of consent through the lifetime of the study (currently 3 years), unless the participant chooses to withdraw from the study. Collection of participant's medical history, including MS and treatment history, will be automated through extraction from the participant's electronic medical record (EMR) and other health information systems (for example, radiology). Participants will complete patient-reported outcomes (PROs) and other health-related information digitally. Participating participants will have access to their own data in an ongoing manner via a web-based Participant Portal.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

Participants willing and able to provide written informed consent
Participants willing to be contacted while participating in the study for recruitment into sub-studies that may be relevant to them
Participants willing and able to complete PROs on a monthly basis and document events of interest as they occur
Participants willing to participate in additional follow up at the site for at least three years

Exclusion Criteria:

Unable to complete questionnaires in English
Unable to consistently access the Internet
Participants participating in interventional clinical drug trials at baseline

Study is for people with:

Multiple Sclerosis

Estimated Enrollment:

10000

Study ID:

NCT04735406

Recruitment Status:

Recruiting

Sponsor:

EMD Serono Research & Development Institute, Inc.

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There are 9 Locations for this study

See Locations Near You

Alabama Neurology Associates
Birmingham Alabama, 35209, United States
Georgetown University
Washington District of Columbia, 20057, United States
Atlanta Neuroscience Institute
Atlanta Georgia, 30327, United States
Beth Israel Deaconess Medical Center
Boston Massachusetts, 02215, United States
Memorial healthcare
Owosso Michigan, 48867, United States
University of Nebraska medical Center
Omaha Nebraska, 68198, United States
The Oklahoma Medical Research Foundation
Oklahoma City Oklahoma, 73104, United States
The University of Texas of Austin
Austin Texas, 78759, United States
University of Texas Health
San Antonio Texas, 78229, United States

How clear is this clinincal trial information?

Study is for people with:

Multiple Sclerosis

Estimated Enrollment:

10000

Study ID:

NCT04735406

Recruitment Status:

Recruiting

Sponsor:


EMD Serono Research & Development Institute, Inc.

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.